(Reuters) – Activist investor Elliott Management has further raised its stake in pharmaceutical services group and takeover target Clinigen Group Plc, a filing showed on Thursday.
Elliott has increased its stake to 10.67% in the company, which on Wednesday agreed to be bought by UK-based Triton Investment Management in a deal valuing it at about 1.2 billion pounds ($1.58 billion).
Elliott, the company’s biggest shareholder, had a 7.61% stake as of Nov. 10, according to Refinitiv Eikon.
($1 = 0.7574 pounds)
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Anil D’Silva)
